• Resmed released its Form 10-K Annual Report for fiscal year 2026
• The company acquired Noctrix Health to expand its sleep health portfolio
• Resmed sold its MatrixCare business for $490 million to focus on core areas
• The company reported a total of 144,252,306 shares outstanding as of August 10, 2026
• Resmed continues to innovate in digital health and cloud-connected medical devices

Resmed Inc. has published its Form 10-K Annual Report for the fiscal year ended June 30, 2026. The report details the company's business operations, financial condition, and results of operations. Notable highlights include the acquisition of Noctrix Health, which expands Resmed's clinical sleep health portfolio, and the sale of its MatrixCare business for $490 million, allowing the company to focus on core growth areas. Resmed also reported having 144,252,306 shares outstanding as of August 10, 2026. The report provides comprehensive information on the company's business strategies, market position, and future outlook.

Resmed expects to close the MatrixCare business sale in Q1 FY 2027.

Resmed anticipates continued growth in its core areas of sleep, breathing, and connected home-based healthcare.